A second cell-binding domain on fibronectin (RGDS-independent) for neurite extension of human neuroblastoma cells.
Human neuroblastoma cells (Platt and La-N1) have previously been shown to adhere and extend neurites on tissue-culture substrata coated with a 120K chymotryptic cell-binding fragment (CBF) of plasma fibronectin (pFN), a fragment which lacks heparan sulfate- and collagen-binding activities, and to adhere to--but not extend neurites on--substrata coated with the heparan sulfate (HS)-binding protein, platelet factor-4 (PF4) (Tobey et al., Exp Cell Res 158 (1985) 395 [3]). The mechanisms of these processes on CBF, on the intact pFN molecule, or on heparin-binding fragments of pFN have been tested using a heptapeptide (peptide A) containing the Arg-Gly-Asp-Ser (RGDS) sequence which recognizes a specific 'receptor' on the surface of a variety of cells or a control peptide with a single amino acid substitution. Adherence and neurite extension were completely inhibited on the 120K CBF by peptide A but not by control peptide; these results indicate that the RGDS-dependent 'receptor' is solely responsible for adhesive responses to the 120K CBF-containing region of the pFN molecule. When peptide A was added to cells on CBF which had already formed neurites to test reversibility, retraction of all neurite processes was induced by 1 h and cells eventually detached. In contrast, on intact pFN, peptide A had very limited effects on either initial adherence or neurite extension, revealing a second 'cell-binding' domain on the fibronectin molecule outside of the 120K region competent for neurite differentiation; addition of peptide A at later times to pFN-adherent, neurite-containing cells could induce only a small subset of neurites to retract, thus supporting evidence for the presence of this second domain. A second 'cell-binding' domain was further confirmed by quantitation of neurite outgrowth on these substrata and by analyses of cells on substrata coated with mixtures of CBF/PF4. When substrata coated with chymotrypsin-liberated HBF were tested in a similar fashion, adherence was rapid but neurite outgrowth required much longer times and was completely sensitive to RGDS peptides; supplementation of cells with the complex ganglioside GT1b could not induce RGDS-resistant neurites on heparin-binding fragments (HBF). These latter results indicate that neurite extension on HBF is a consequence of a low concentration of RGDS-dependent activity in HBF (but not to HS-binding activity as characterized by Tobey et al. [3]) and that the second 'cell-binding' domain is sensitive to chymotrypsin digestion of pFN during the liberation of HBF.(ABSTRACT TRUNCATED AT 400 WORDS)